Authors:
Xu, YC
Johnson, KW
Phebus, LA
Cohen, M
Nelson, DL
Schenck, K
Walker, CD
Fritz, JE
Kaldor, SW
LeTourneau, ME
Murff, RE
Zgombick, JM
Calligaro, DO
Audia, JE
Schaus, JM
Citation: Yc. Xu et al., N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy, J MED CHEM, 44(24), 2001, pp. 4031-4034